Join Ads Marketplace to earn through podcast sponsorships.
Manage your ads with dynamic ad insertion capability.
Monetize with Apple Podcasts Subscriptions via Podbean.
Earn rewards and recurring income from Fan Club membership.
Get the answers and support you need.
Resources and guides to launch, grow, and monetize podcast.
Stay updated with the latest podcasting tips and trends.
Check out our newest and recently released features!
Podcast interviews, best practices, and helpful tips.
The step-by-step guide to start your own podcast.
Create the best live podcast and engage your audience.
Tips on making the decision to monetize your podcast.
The best ways to get more eyes and ears on your podcast.
Everything you need to know about podcast advertising.
The ultimate guide to recording a podcast on your phone.
Steps to set up and use group recording in the Podbean app.
Join Ads Marketplace to earn through podcast sponsorships.
Manage your ads with dynamic ad insertion capability.
Monetize with Apple Podcasts Subscriptions via Podbean.
Earn rewards and recurring income from Fan Club membership.
Get the answers and support you need.
Resources and guides to launch, grow, and monetize podcast.
Stay updated with the latest podcasting tips and trends.
Check out our newest and recently released features!
Podcast interviews, best practices, and helpful tips.
The step-by-step guide to start your own podcast.
Create the best live podcast and engage your audience.
Tips on making the decision to monetize your podcast.
The best ways to get more eyes and ears on your podcast.
Everything you need to know about podcast advertising.
The ultimate guide to recording a podcast on your phone.
Steps to set up and use group recording in the Podbean app.
Randy Baron, one of the most popular YAVP guests, returns to discuss his investment thesis on Renalytix (RNLX). Randy sees similarities between RNLX and EXAS, which was a controversial stock that has rocketed over the last few years as the company's diagnostic product gained momentum. While not without risk, Randy thinks RNLX could be even bigger if successful as they are attacking the much larger Chronic Kidney Disease (CKD) market, and he discusses all of the signs he sees that the company is about to inflect.
Randy's first appearance on Amyris (AMRS): https://www.youtube.com/watch?v=zCKxUHfCoQQ&t=1s
Chapters
0:00 Intro
1:20 RNLX overview
8:55 Where does RNLX fall into CKD?
14:00 Why now is the time for RNLX in CKD
20:40 How RNLX can operate even without MICT
24:30 More on RNLX and Medicare
25:30 When will RNLX get FDA approval?
33:40 What if RNLX doesn't get FDA approval?
37:30 RNLX's CEO and founder, James McCullough
43:40 Why is RNLX so under the radar?
46:40 Comping RNLX to Theranos
50:00 Randy's closing thoughts
Random Ramblings September 2024: heavy selection bias, probabilities & terminal 0's, returns on fame
MDC Financial Research's Michael Cohen provides his post-game report on $ACI / $KR case
Choice Equities' Mitchell Scott provides update on $CROX thesis and thoughts on Magnite $MGNI
Value Situations' Conor Maguire on why strategic review at Dowlais $DWL.L indicates a live catalyst
Arbiter Partners' Ross Levin talks betting on French compounding legend, Vincent Bolloré
Marathon Partners' Mario Cibelli on digital remittances company, Remitly $RELY
MDC Financial Research's Michael Cohen provides his halftime report on $ACI / $KR case
Chris DeMuth's State of the Markets August 2024
Cedar Grove's Paul Cerro on what makes $RCAT drones unique + odds for winning SRR contract
Clayton Partners' Jason Stankowski and Brian Lancaster on why Mattr $MATR.TO is misunderstood
Rhizome Partners' Bill Chen updates his publicly traded real estate thesis+ $AIV pitch
Random Ramblings August 2024: crazy start to August, due diligence trips, seeing management teams
Chris DeMuth's State of the Markets July 2024
Rome Capital's Alex Feng and Jason Quan making the case for Samsonite $1910.HK
Random Ramblings July 2024: stock price driving narrative + investing in products you don't like
Net Interest's Marc Rubinstein on "The Trump Trade" + deep dive on $FNMA
Atla Capital Management's John Haskell on international real estate + ESR Group thesis $1821.HK
Chris DeMuth's State of the Markets June 2024
Maverick Value's Ron Nussbaum on the legal and fundamental cases for $CPRI / $TPR combination
Buckley Capital's Zack Buckley on why he's urging $DNTL.TO to undertake a strategic review process
Create your
podcast in
minutes
It is Free
The Minority Mindset Show
U.S Property Podcast
Dubai Property Podcast
The Ramsey Show
The Clark Howard Podcast